175 related articles for article (PubMed ID: 29998292)
1. Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions.
Hornberger J; Siegel DM
JAMA Dermatol; 2018 Sep; 154(9):1025-1031. PubMed ID: 29998292
[TBL] [Abstract][Full Text] [Related]
2. Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy.
Ferris LK; Jansen B; Ho J; Busam KJ; Gross K; Hansen DD; Alsobrook JP; Yao Z; Peck GL; Gerami P
JAMA Dermatol; 2017 Jul; 153(7):675-680. PubMed ID: 28445578
[TBL] [Abstract][Full Text] [Related]
3. Non-Invasive Gene Expression Testing to Rule Out Melanoma.
Rivers JK; Copley MR; Svoboda R; Rigel DS
Skin Therapy Lett; 2018 Sep; 23(5):1-4. PubMed ID: 30248161
[TBL] [Abstract][Full Text] [Related]
4. Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions.
Ferris LK; Gerami P; Skelsey MK; Peck G; Hren C; Gorman C; Frumento T; Siegel DM
Melanoma Res; 2018 Oct; 28(5):478-482. PubMed ID: 30004988
[TBL] [Abstract][Full Text] [Related]
5. Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study.
Ferris LK; Rigel DS; Siegel DM; Skelsey MK; Peck GL; Hren C; Gorman C; Frumento T; Jansen B; Yao Z; Rock J; Knezevich SR; Cockerell CJ
Dermatol Online J; 2019 May; 25(5):. PubMed ID: 31220892
[TBL] [Abstract][Full Text] [Related]
6. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
7. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
[TBL] [Abstract][Full Text] [Related]
8. Pigmented Lesion Assay for Suspected Melanoma Lesions: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(5):1-81. PubMed ID: 34188732
[TBL] [Abstract][Full Text] [Related]
9. Budget impact analysis of a novel gene expression assay for the diagnosis of malignant melanoma.
Cassarino DS; Lewine N; Cole D; Wade B; Gustavsen G
J Med Econ; 2014 Nov; 17(11):782-91. PubMed ID: 25170544
[TBL] [Abstract][Full Text] [Related]
10. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study.
Carli P; Nardini P; Crocetti E; De Giorgi V; Giannotti B
Melanoma Res; 2004 Oct; 14(5):403-7. PubMed ID: 15457097
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.
Gerami P; Yao Z; Polsky D; Jansen B; Busam K; Ho J; Martini M; Ferris LK
J Am Acad Dermatol; 2017 Jan; 76(1):114-120.e2. PubMed ID: 27707590
[TBL] [Abstract][Full Text] [Related]
12. Investment in new technology research can save future health care dollars.
Reintgen D; Albertini J; Milliotes G; Marshburn J; Cruse CW; Rapaport D; Berman C; Glass F; Fensske N; Einstein AB; Lyman G
J Fla Med Assoc; 1997 Mar; 84(3):175-81. PubMed ID: 9143169
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Analysis of High-Risk Driver Mutations and Gene Expression Profiles in Primary Cutaneous Melanoma.
Ferris LK; Moy RL; Gerami P; Sligh JE; Jansen B; Yao Z; Cockerell CJ
J Invest Dermatol; 2019 May; 139(5):1127-1134. PubMed ID: 30500343
[TBL] [Abstract][Full Text] [Related]
14. An estimate of the annual direct cost of treating cutaneous melanoma.
Tsao H; Rogers GS; Sober AJ
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809
[TBL] [Abstract][Full Text] [Related]
15. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.
Shoo BA; Sagebiel RW; Kashani-Sabet M
J Am Acad Dermatol; 2010 May; 62(5):751-6. PubMed ID: 20303612
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas.
Friedman RJ; Gutkowicz-Krusin D; Farber MJ; Warycha M; Schneider-Kels L; Papastathis N; Mihm MC; Googe P; King R; Prieto VG; Kopf AW; Polsky D; Rabinovitz H; Oliviero M; Cognetta A; Rigel DS; Marghoob A; Rivers J; Johr R; Grant-Kels JM; Tsao H
Arch Dermatol; 2008 Apr; 144(4):476-82. PubMed ID: 18427041
[TBL] [Abstract][Full Text] [Related]
17. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma.
Abbasi NR; Yancovitz M; Gutkowicz-Krusin D; Panageas KS; Mihm MC; Googe P; King R; Prieto V; Osman I; Friedman RJ; Rigel DS; Kopf AW; Polsky D
Arch Dermatol; 2008 Apr; 144(4):469-74. PubMed ID: 18427040
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the diagnosis of pigmented tumors of the skin and factors leading to a decision to excise. Dermatologists of the Postgraduate Association of Haute-Normandie].
Collas H; Delbarre M; De Preville PA; Courville P; Neveu C; Dompmartin A; Balguerie X; Lemaistre B; Rzeznik JC; Thiebot B; Boullie MC; Bravard P; Michel Y; Krug M; Le Corvaisier-Pieto C; Young P; Thomine E; Boivin C; Ziade J; Pellerin A; Hellot MF; Leroy D; Lauret P; Benichou J; Joly P
Ann Dermatol Venereol; 1999; 126(6-7):494-500. PubMed ID: 10495858
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
